Navigation Links
When It Comes to Pregnancy, Timing Is Everything
Date:4/3/2008

Too little -- or too much -- time between births can be risky, research suggests

THURSDAY, April 3 (HeathDay News) -- First, there's the initial baby question: When is the right time to have your first child?

Turns out, that's just the beginning. Equally important is figuring out when to have the next baby -- if you decide to have more than one.

The proper timing of pregnancies, experts say, can decrease your risk of having a baby born premature and with a host of health problems.

Intervals that are too brief -- as well as those that are too long -- aren't desirable, research suggests.

In one of the latest studies, researchers from Washington University in St. Louis evaluated more than 156,000 women from Missouri who had two births from 1989 to 1997. The researchers looked at the intervals between pregnancies and the outcomes for those pregnancies. The study, led by Dr. Emily DeFranco, a clinical fellow in maternal-fetal medicine and a staff member at Washington University's Center for Preterm Birth Research, was published recently in the American Journal of Obstetrics and Gynecology.

Among the findings, according to DeFranco:

  • Intervals of less than six months from delivery to conception of the next baby increased the risk of preterm birth (less than 35 weeks) by 41 percent.
  • Intervals of six to 12 months increased preterm birth risk by 14 percent.
  • Intervals of 12 to 18 months carried no significant increased risk of preterm birth.

"Wait a minimum of 12 months before becoming pregnant again," DeFranco advised. That's to say, let 12 months or more go by after delivery before you start trying again to become pregnant. That advice is especially crucial for women who have already had a preterm birth, which raises the preterm risk in subsequent pregnancies, she said.

In another report, published in April 2006 in the Jo
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Houston-Based LifeGift Becomes States Only Stand-Alone Organ and Tissue Recovery Agency
2. Leventhal Weight Loss Incorporated Becomes First in the Nation Executive Weight Loss Consulting Service for Attorneys by an Attorney
3. Drug-coated balloon overcomes in-stent restenosis
4. Anticoagulant Drugs Had Similar Outcomes After Angioplasty
5. Comparison of anticoagulants for angioplasty show similar outcomes
6. Spartan Stores Becomes Largest U.S. Supermarket Chain to Receive NSF Shop Fresh(TM) Certification
7. Head and Neck Cancer Outcomes a Mixed Bag
8. MTM Study Reports Improved Quality and Economic Outcomes Using Medication Management Systems Assurance Pharmaceutical Care System(TM)
9. Specialized Care for Ovarian Cancer Improves Outcomes
10. Outcomes Improve for Non-Hodgkin Lymphoma Patients
11. Therap Services Welcomes Anna Keith to the US Customer Support Team
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
When It Comes to Pregnancy, Timing Is Everything
When It Comes to Pregnancy, Timing Is Everything
Breaking Medicine Technology:Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 2Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 3Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7Royalty Pharma Announces that Alexander von Perfall Joins Management Team 24th BTLtec Conference on 24 25 Sep in Graz Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies 13115 14th BTLtec Conference on 24 25 Sep in Graz Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies 13115 24th BTLtec Conference on 24 25 Sep in Graz Austria features Biomass to Liquids Innovators Sharing Updates on Pyrolysis and Gasification Technologies 13115 3HealthCare Partners of Nevada and Fremont Medical Center Join Forces 52190 1HealthCare Partners of Nevada and Fremont Medical Center Join Forces 52190 2Tiffany Diamond Eternity Bands and Cartier 26apos 3BLove 26apos 3B Rings 3A Beladora Announces Sharp Wedding Jewelry Sales Increase 52188 1Tiffany Diamond Eternity Bands and Cartier 26apos 3BLove 26apos 3B Rings 3A Beladora Announces Sharp Wedding Jewelry Sales Increase 52188 2Tiffany Diamond Eternity Bands and Cartier 26apos 3BLove 26apos 3B Rings 3A Beladora Announces Sharp Wedding Jewelry Sales Increase 52188 3